EirGen Pharma receives Approval for Eir-047 from US FDA
EirGen Pharma are pleased to announce that notification was received from US FDA for license approval of our breast cancer product Eir-047. This is a major milestone for EirGen as our first US prouct approval and builds on site approval that was recently received.
EirGen Pharma is a pharmaceutical company based in Waterford, Ireland. Using its purpose built high containment facility; the company specialises in the development, registration and manufacture of high potency solid dose products for global markets.